Search Results 8991-9000 of 44034 for oral
... oral or parenteral antibacterial therapy for a non-CDI indication after randomization. Note: Other protocol defined Inclusion/Exclusion Criteria may apply ...
Oral and throat cancer; Oropharyngeal cancer; Radiation injury; Salivary gland cancer; Skin cancer · Thyroid cancer · Procedures performed · Intensity-modulated ...
Fellows should expect to submit and participate in scientific meetings each year, with oral presentations, videos, or poster presentations. Mayo Clinic ...
Oral case presentation and discussion; Peer-group discussion; Journal club; Teaching rounds; Morbidity and mortality conferences. Additional conferences. There ...
... . Departments that treat this condition. Cancer Care at Mayo Clinic · Head and Neck Cancer Center · Oncology (Medical) · Oral and Maxillofacial Surgery ...
... Oral and throat cancer, Head and neck cancer, Skin cancer, Oropharyngeal cancer, Mouth cancer, Thyroid cancer, Melanoma, Squamous cell carcinoma of the skin ...
This is a multicenter, double-blind, parallel-group, placebo-controlled, study to assess the efficacy, safety, and PK of ZX008 when used as adjunctive therapy ...
A study cycle will consist of daily and continuous oral administration of BBI608 for four weeks (28 days) in combination with FOLFOX6 with and without ...
Radiation therapy uses high-energy x-rays and other types of radiation to kill tumor cells and shrink tumors. Specialized radiation therapy that delivers a high ...
Third Place Award for Oral Presentation "CT Angiography and Perfusion Studies..."American Academy of Neurology. 2011. Manfred D. Muenter Award for ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.